Fetal Genotype-Phenotype Sex Discordance: A Case of 5-Alpha-Reductase Deficiency

Fetal Pediatr Pathol. 2022 Oct;41(5):794-799. doi: 10.1080/15513815.2021.1948645. Epub 2021 Jul 12.

Abstract

Objective: To describe the prenatal and postnatal diagnostic workup leading to the diagnosis of 5-alpha-reductase type 2 deficiency (5AR2D) in a case of 46,XY disorder of sex development (DSD).

Case report: A first-trimester noninvasive prenatal test (NIPT) on maternal blood revealed a male fetus with a low risk of aneuploidy. However, a female fetus was identified at the second-trimester scan. A repeat sample revealed similar results and ruled out the possibility of both a sample swap or a vanishing twin. At birth, phenotypically female external genitalia were evident, with testes noted in the labioscrotal area. Neonatal blood confirmed a 46,XY complement and a 46,XY DSD genetic panel revealed a 5AR2D.

Conclusion: Our case and others described in the literature demonstrate that fetal sex discordance detected by a combination of NIPT and subsequent ultrasound examination can be associated with several biological conditions, with DSD being the most significant.

Keywords: 5-alpha-reductase deficiency; Fetal sex discordance; disorders of sexual development; fetal ultrasound; noninvasive prenatal testing.

Publication types

  • Case Reports

MeSH terms

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase* / deficiency
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase* / genetics
  • Disorder of Sex Development, 46,XY* / genetics
  • Female
  • Genotype
  • Humans
  • Hypospadias
  • Male
  • Phenotype
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Steroid Metabolism, Inborn Errors

Substances

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

Supplementary concepts

  • Pseudovaginal Perineoscrotal Hypospadias